<div style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;"><span style="font-size: 12.8px;">India and China have reached an agreement on </span>reduction<span style="font-size: 12.8px;"> of tariffs on Chinese imports of Indian medicines, particularly cancer drugs. </span></div>''<div style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;"><br />''</div>''<div style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;">Chinese foreign ministry spokesperson Hua Chunying told a media briefing in Beijing that both the countries have reached agreement on the reduction of tariffs on anti-cancer medicines. He said the agreement will also usher in great opportunities for India and other countries in the region. </div>''<div style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;"><br />''</div>''<div style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;">Both India and China slashed import tariffs of a range of products starting July 1, following the fourth round of negotiations under the Asia Pacific Trade Agreement (APTA), which also includes Bangladesh, Laos, South Korea and Sri Lanka. </div>''<div style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;"><br />''</div>''<div style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;">Indian drugs, specially cancer curing medicines, are in big demand in China as they are far cheaper than their western counterparts.  </div>''<div class="yj6qo" style="color: #222222; font-family: arial, sans-serif; font-size: 12.8px;"></div>